Is Unidrug Innovative Pharma Technologies a good quality company?

Data is not available for this company.

What is Unidrug Innovative Pharma Technologies share price return in the past 10 years?

Data is not available for this company

What is the P/E ratio of Unidrug Innovative Pharma Technologies?

The latest standalone P/E ratio of Unidrug Innovative Pharma Technologies as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Unidrug Innovative Pharma Technologies?

The latest standalone P/B ratio of Unidrug Innovative Pharma Technologies as of 01-Jan-1970 is 0.00.

What is the 52-week high and low of Unidrug Innovative Pharma Technologies?

The 52-week high of Unidrug Innovative Pharma Technologies is Rs. 0.00 and the 52-week low is Rs. 0.00.

Unidrug Innovative Pharma Technologies Ltd - Stock Valuation and Financial Performance

Name: Unidrug Innovative Pharma Technologies
Brand: Unidrug Innovative Pharma Technologies

BSE: 0 | NSE: | Pharmaceuticals & Drugs | Small Cap

Place order

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Unidrug Innov.Pharma

Based on:

Data

DeciZen not available for IPO

10 Year X-Ray of Unidrug Innov.Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	TTM
ROCE % ⓘ	6.4%	7.8%	10.5%	11.9%	6.6%	9.3%	6.7%	7.3%	20.5%	28.4%	-
Value Creation Index ⓘ	-0.5	-0.4	-0.3	-0.2	-0.5	-0.3	-0.5	-0.5	0.5	1.0	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	23.7	23.4	19.2	20.6	23.9	29	27.7	26.2	32.5	30.9	31
Sales YoY Gr.	-	-1.1%	-18.1%	7.4%	16.2%	21.3%	-4.6%	-5.3%	23.9%	-5.1%	-
Adj EPS ⓘ	0.2	0.4	0.7	1.2	0.1	0.7	0.2	0.3	2.3	4.2	4.2
YoY Gr.	-	94.7%	94.6%	69.4%	-95.1%	1016.7%	-65.7%	34.8%	625.8%	84.9%	-
BVPS (₹) ⓘ	5.5	5.7	5.9	6.1	6.3	6.5	6.7	6.9	8.8	13	20.5
Adj Net Profit ⓘ	0.1	0.3	0.6	0.9	0	0.5	0.2	0.2	1.7	3.2	3
Cash Flow from Ops. ⓘ	0	0	0	0	0	4.8	0	1	2.2	-0.7	-
Debt/CF from Ops. ⓘ	0	0	0	0	0	1.3	0	3.7	1.2	-6.3	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	3%	5.2%	3.7%	-5.1%
Adj EPS ⓘ	40.9%	133.5%	162.5%	84.9%
BVPSⓘ	10.2%	15.6%	24.7%	47.6%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	TTM
Return on Equity % ⓘ	3.5	6.7	12.3	20.1	0.9	10.5	3.5	4.5	28.7	38.1	25.1
Op. Profit Mgn % ⓘ	4.6	5.4	9.2	11	5.4	5.8	3.9	3.5	8.4	16	NAN
Net Profit Mgn % ⓘ	0.6	1.2	2.9	4.5	0.2	1.8	0.7	0.9	5.3	10.3	10.4
Debt to Equity ⓘ	1.5	1.5	1.6	2	2	1.2	0.8	0.7	0.4	0.5	-
Working Cap Days ⓘ	155	173	232	242	219	182	183	167	145	174	0
Cash Conv. Cycle ⓘ	78	81	120	142	118	83	59	61	52	85	0

Recent Performance Summary

Recent Performance Summary not available for IPO

Latest Financials - Unidrug Innovative Pharma Technologies Ltd.

	Standalone	Consolidated
TTM EPS (₹)	4.2	-
TTM Sales (₹ Cr.)	30.9	-
BVPS (₹.) ⓘ	20.5	-
Reserves (₹ Cr.) ⓘ	8	-
P/BV ⓘ	0.00	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	0.00 / 0.00
All Time Low / High (₹)	- / -
Market Cap (₹ Cr.)	0
Equity (₹ Cr.)	7.7
Face Value (₹)	10
Industry PE ⓘ	48.8

Management X-Ray of Unidrug Innov.Pharma:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Unidrug Innov.Pharma

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Unidrug Innov.Pharma

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Sales	23.68	23.43	19.18	20.59	23.93	29.03	27.71	26.23	32.50	30.86
Operating Expenses ⓘ	22.59	22.30	17.93	19.48	22.65	27.89	26.62	25.32	29.90	25.93
Manufacturing Costs	3.40	3.67	2.65	3.18	0	3.85	0.78	3.97	5.29	5.84
Material Costs	18.25	17.17	14.03	14.13	17.47	22.41	21.47	19.16	21.02	17.13
Employee Cost	0.27	0.34	0.37	0.47	0.58	0.61	0.66	1.12	1.61	1.78
Other Costs ⓘ	0.67	1.12	0.88	1.69	4.60	1.02	3.70	1.08	1.99	1.17
Operating Profit ⓘ	1.09	1.13	1.24	1.11	1.28	1.14	1.09	0.91	2.61	4.93
Operating Profit Margin (%)	4.6%	4.8%	6.5%	5.4%	5.4%	3.9%	3.9%	3.5%	8.0%	16.0%
Other Income ⓘ	0.28	0.12	0.12	0.12	0.43	0.16	0.14	0.27	0.07	0.16
Interest ⓘ	0.75	0.78	0.91	0.88	1.28	0.95	0.71	0.61	0.23	0.31
Depreciation ⓘ	0.24	0.27	0.25	0.24	0.23	0.14	0.26	0.23	0.18	0.28
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	-0.22	0
Profit Before Tax ⓘ	0.37	0.20	0.20	0.10	0.19	0.21	0.26	0.34	2.05	4.50
Tax ⓘ	0.12	0.02	0.01	-0.05	0.06	0.07	0.08	0.11	0.55	1.28
Profit After Tax	0.26	0.18	0.19	0.15	0.13	0.14	0.18	0.23	1.49	3.22
PAT Margin (%)	1.1%	0.8%	1.0%	0.7%	0.5%	0.5%	0.6%	0.9%	4.6%	10.4%
Adjusted EPS (₹)	0.3	0.2	0.3	0.2	0.2	0.2	0.2	0.3	2.0	4.2
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Equity and Liabilities
Shareholders Fund	4.18	4.36	4.56	4.71	4.83	4.97	5.15	5.28	6.77	9.99
Share Capital ⓘ	1.97	1.97	1.97	1.97	1.97	1.97	1.97	1.97	1.97	1.97
Reserves ⓘ	2.22	2.40	2.59	2.74	2.87	3.01	3.19	3.31	4.80	8.02
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	6.25	6.46	7.35	9.40	9.68	5.88	4.05	3.65	2.72	4.46
Long Term Debt	6.25	6.46	1.69	2.65	1.98	1.54	1.11	0.78	0.60	0.96
Short Term Debt	0	0	5.66	6.75	7.69	4.34	2.94	2.87	2.12	3.49
Trade Payables	3.81	3.96	4.17	3.75	4.93	7.15	6.36	4.80	6.79	3.64
Others Liabilities ⓘ	0.74	1.11	0.73	0.62	1.06	0.95	0.73	1.34	1.49	1.11
Total Liabilities ⓘ	14.99	15.90	16.80	18.48	20.51	18.95	16.30	15.06	17.78	19.20
Fixed Assets
Gross Block	5.11	5.05	5.03	4.77	4.98	5.09	5.40	5.74	5.61	6.11
Accumulated Depreciation	1.62	1.74	1.95	2.08	2.31	2.40	2.66	2.86	2.94	3.10
Net Fixed Assetsⓘ	3.49	3.31	3.08	2.69	2.67	2.69	2.74	2.87	2.67	3.01
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0.07
Investmentsⓘ	0.22	0.22	0.22	0.22	0.22	0.22	0.22	0.22	0	0
Inventories	3.40	3.14	4.41	4.62	5.69	6.30	3.69	2.13	3.28	4.41
Trade Receivables	5.21	6.92	7.11	8.79	9.63	7.25	7.41	7.86	9.19	9.57
Cash Equivalents	0.60	0.74	0.77	0.96	0.83	0.74	0.82	0.45	0.88	0.95
Others Assetsⓘ	2.07	1.57	1.21	1.21	1.46	1.75	1.42	1.54	1.76	1.20
Total Assets ⓘ	14.99	15.90	16.80	18.48	20.51	18.95	16.30	15.06	17.78	19.20

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'17	Mar'18	Mar'19
Cash Flow From Operating Activity ⓘ	4.75	0.98	2.19	-0.72
PBT ⓘ	0.21	0.34	2.05	4.50
Adjustment ⓘ	1.02	0.78	1.25	0.54
Changes in Working Capital ⓘ	3.56	-0.05	-0.88	-4.5
Tax Paid ⓘ	-0.04	-0.08	-0.23	-1.26
Cash Flow From Investing Activity ⓘ	-0.10	-0.34	-0.59	-0.64
Capex	-0.17	-0.40	-0.64	-0.70
Net Investments	0	0	0	0
Others ⓘ	0.07	0.05	0.05	0.06
Cash Flow From Financing Activityⓘ	-4.75	-1.01	-1.16	1.42
Net Proceeds from Shares ⓘ	0	0	0	0
Net Proceeds from Borrowing ⓘ	-0.44	-0.33	-0.18	0.36
Interest Paid ⓘ	-0.95	-0.61	-0.23	-0.31
Dividend Paid ⓘ	0	0	0	0
Others ⓘ	-3.35	-0.06	-0.75	1.37
Net Cash Flow ⓘ	-0.09	-0.37	0.44	0.06

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Ratios
ROE (%)	6.33	4.3	4.27	3.29	2.66	2.84	3.54	4.5	24.78	38.44
ROCE (%)	10.85	9.21	9.79	7.6	10.3	9.12	9.56	10.53	24.71	40.13
Asset Turnover Ratio	1.68	1.52	1.17	1.17	1.34	1.63	1.57	1.67	1.98	1.67
PAT to CFO Conversion(x)	18.27	0	5.16	14.6	-5.54	0	0	0	0	0
Working Capital Days
Receivable Days	79	94	133	141	129	96	97	106	96	111
Inventory Days	49	51	72	80	72	68	66	40	30	45
Payable Days	61	83	106	102	91	98	115	106	101	111

Unidrug Innovative Pharma Technologies Ltd Stock News

Unidrug Innovative Pharma Technologies Ltd FAQs

What is the share price of Unidrug Innov.Pharma?

Company share prices are keep on changing according to the market conditions. The closing price of Unidrug Innov.Pharma on 01-Jan-1970 05:30 is ₹0.00.

What is the market cap of Unidrug Innov.Pharma?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Unidrug Innov.Pharma stood at ₹0.00.